The formation of pseudouridine (v) in human Ul, U2 and U5 small nuclear RNAs (snRNAs) was investigated using HeLa cell extracts. Unmodified snRNAs were synthesized in vitro and the extent of T formation was determined after incubation in cell extracts. The formation of on labelled substrates was monitored in the presence of 5-fluorouracil (5-FU)-containing snRNAs as inhibitors of T formation. The conversion of uridine to was inhibited only when the cognate 5-FU-containing inhibitor snRNA was included in the reaction. For example, 5-FU-containing Ul RNA inhibited T formation in unmodified Ul RNA, but not in (unmodified) U2 or U5 RNAs. The results
INTRODUCTION
The splicing of pre-mRNA requires several small nuclear ribonucleoprotein particles (snRNPs [1, 2] ). These include Ul, U2, U5 and U4/U6 snRNPs, which are composed of at least one highly conserved small nuclear RNA (snRNA) and a cohort of proteins that include both common (Sm) proteins and snRNPspecific proteins [3] [4] [5] .
These snRNAs are highly modified post-transcriptionally, and pseudouridine (T) represents by far the most abundant of these modifications [3] . The positions of in snRNAs from different species are highly conserved. Moreover, there are Ts in regions of Ul and U2 RNAs that are known to be necessary for the function of these cofactors in splicing [1, 2] . However, the actual function of in snRNAs is not yet known. is necessary both for the interaction of tRNAs with the ribosome [6, 7] and for the efficient reading of codons during translation [8] . Studies of his T mutants (his T codes for synthase) in bacteria suggest that the presence of in the anticodon region of tRNA is not required for cell growth [9, 10] . Recently Tsui et al. [11] found that his T function was required for normal growth of Escherichia coli K-12 on minimal media. The mutation causes a uracil requirement that interferes with cell division [11] .
Enzymes that convert uridine to in tRNAs have been purified from a number of sources [12] [13] [14] . There appear to be multiple enzymes that modify tRNAs [12, 13] . Several inhibitors of synthases have been identified, most notably 5-fluorouracil (5-FU)-substituted tRNAs [12, 15, 16] . Enzymes that form T in snRNAs have not been purified, but the formation of T in U5 RNA has been studied in HeLa cell extracts [17] . The modifications are site-specific, and the binding of Sm proteins to the U5 RNA is required for formation [17] .
In the present paper an in vitro assembly system for snRNPs is combined with the use of specific inhibitors of synthase to study the formation of T in Ul, U2 and U5 snRNAs. The results show that there are at least three activities that modify these snRNAs and that each is specific for a particular snRNA. In addition, these studies show that 5-FU-containing snRNAs are potent inhibitors of T formation in snRNAs.
suggest that there are at least three activities that form in these snRNAs. The 5-FU-containing RNAs were stable during incubation in the cell extracts. A 12-fold molar excess of unlabelled Ul RNA did not inhibit formation on a labelled Ul RNA substrate, whereas a 3-fold molar excess of 5-FU-containing U1 RNA nearly abolished T formation on the Ul substrate. The fact that 5-FU-containing snRNAs are potent inhibitors of formation in these pre-mRNA splicing cofactors raises the possibility that this is related to the cytotoxicity of fluoropyrimidines in cancer chemotherapy.
MATERIALS AND METHODS
Human U1, U2 and U5 RNAs were transcribed as described [18] using BamHI-cut pHUl DNA [19] , MaeI-cut pHU5a2 DNA [17] and SmaI-cut pMRG3U2-27 DNA (a gift from Dr. T. Pederson). In the latter case the resulting U2 RNA has an additional three G residues at the 5' end of the transcript. The lengths of in vitrotranscribed Ul and U5 RNAs have been described [17, 19] . For the snRNA stability experiment (Figure 3 ), BamHI-cut pG2U2Pre (a gift from Dr. A. Kleinschmidt) was used. The resulting U2 RNA transcript has an additional 18 nucleotides on the 5' end and an additional 11 nucleotides on the 3' end [20] . The Ul and U5 RNAs were transcribed with SP6 RNA polymerase, whereas U2 RNA was transcribed by T7 RNA polymerase. The human pre-tRNAser RNA was transcribed with T7 RNA polymerase using Aval-cut pUC19pSer (a gift from Dr. C. Guerrier-Takada and Dr. S. Altman). The full description of the pUC l9pSer clone is unpublished, but the pre-tRNASer transcript is 123 nucleotides in length and has extensions on both the 5' and 3' ends of mature tRNASer. When 25 ,uM. All RNAs were gel-purified before use [17] .
The in vitro snRNP assembly reactions were carried out as described [19, 20] using a HeLa S100 cell extract [21] . The Abbreviations used: snRNA, small nuclear RNA; snRNP, small nuclear ribonucleoprotein particle; 5-FU, 5-fluorouracil; T, pseudouridine.
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RNAs and then incubated at 37°C for an additional 60 min unless otherwise noted.
Glycerol gradient centrifugation of the assembled snRNPs, antibody selection of Sm antigen-containing snRNPs, RNAase Tl digestion of Ul and U2 RNAs and the assays for ' formation were carried out as described previously [17] . Procedures for gel electrophoresis and elution of the RNAs from the gel have been described previously [19, 20] .
RESULTS
Location of vI residues In snRNAs assembled in vitro ' is found at nucleotides 5 and 6 in human Ul RNA, nucleotides 43, 46 and 53 in human U5 RNA, and at 13 positions in rat U2 RNA (Figure 1 ; see also [3] ). The extract (S100) used for the in vitro assembly of these snRNPs is known to support the conversion of uridine to T [17, 19, 20] . In the case of U5 RNA, two of the three positions (at nucleotides 43 and 46) are modified in vitro [17] . The actual sites of modification in U1 and U2 RNAs assembled in vitro have not been defined [19, 20] . To determine the specificity of ' formation in Ul and U2 RNAs, [32P]UTPlabelled Ul and U2 RNAs were incubated in extracts and RNA from glycerol-gradient-purified snRNPs was isolated. The RNA was digested with RNAase TI and the resulting fragments were electrophoresed on a 20% polyacrylamide/8 M urea gel. The appropriately sized bands, identified by autoradiography, were eluted from the gel, and the RNA was isolated and digested with nuclease P1 [19, 20] . The reaction products were chromatographed on t.l.c. plates (cellulose) in one dimension (propan-2-ol/conc. HCl/water, 70:15:15, by vol.) and autoradiographed [17, 23] .
When Ul RNA was incubated in the reaction, only the 5' end RNAase Ti fragment contained ' (Figure 2a ). This is the only TI fragment that is predicted to contain T, based on the known sequence of human Ul RNA [3] . Therefore, as with U5 RNA [17] , the formation of ' in Ul RNA in vitro mimics the reaction in vivo.
The positions of ' in human U2 RNA are not known, but they are predicted to be the same as in rat U2 RNA (see Figure  1 ; [3] ). When human U2 RNA was incubated in the extracts, the bands at 15, 11, 10, 7 and 6 nucleotides all contained ' ( Figure  2b ) and, given the location of ' in rat U2 RNA, these would be the Ti fragments that are predicted to contain ' in human U2 RNA. There is no ' in the 5-nucleotide fragment, as one would predict.
Most importantly, this snRNP assembly system supports T formation in human U 1, U2 and U5 RNAs, and the modifications occur at specific positions. The extracts contain highly specific enzymic activities that appear to be modifying only those uridine residues that are normally modified in vivo [17] .
Multiple vI synthases for the modffication of snRNAs Although U 1, U2 and U5 RNAs have a number ofcharacteristics in common, the positions of T residues with respect to the sequence and secondary structure of the snRNAs are very different (see Figure 1 ). Does the same snRNA ' synthase act on all snRNAs, or are there separate synthases for each snRNA? In order to answer this question, very specific inhibitors of the activities were needed. Samuelsson [15] found that tRNAs containing 5-FU were very specific and potent inhibitors of tRNA T synthases. Two types of RNA, one transcribed in the presence of UTP and the other in the presence of 5-fliuoro-UTP,
[3H]ATP) was included in the reaction in order to estimate the amount of RNA produced.
Several studies have shown that in vitro-transcribed snRNAs assemble into stable RNPs during incubation in these extracts [17, 19, 20] , but the effect of substituting 5-FU for uridine on particle assembly or RNA stability has not been studied. To determine if the stability of the RNAs was affected by the presence of 5-FU, both types of RNA were incubated in the extracts for up to 1 h. Figure 3 shows that the 5-FU-containing snRNAs were quite stable in the extracts, with only a slight increase in turnover when compared with transcripts without 5-FU. The U2 RNA used in this particular experiment was processed at the 3' end in these extracts, since it has a 11-nucleotide extension on the 3' end [20] . The presence of the smaller band is quite evident for U2 RNA without 5-FU. The 5-FU-containing U2 RNA is processed, albeit less efficiently since precursor U2 RNA is evident even after 1 h of incubation. The additional band between U2 and Ul RNAs at zero time is Ul RNA transcript that has not been processed by RNAase H due to lack of incubation at 37 'C. An antisense oligodeoxynucleotide that hybridizes to the last 25 nucleotides of the Ul RNA in vitro transcript is included in all reactions in order to obtain Ul RNA that has a correct 3' end [19] .
These same 5-FU-containing RNAs, as well as pre-tRNAser with and without 5-FU, were used to determine the synthase activity in extracts. In Table 1 , the amount of 3H released [17, 22] in 2 h from gel-purified Ul, U2 and U5 RNAs was determined after incubation of these 3H-labelled substrates in the assembly reaction in the presence of possible inhibitors. The 5-FUcontaining inhibitor RNAs were incubated in the reactions for 10 min prior to the addition of 3H-labelled substrate RNAs. 3H is released from the C-5 position of [5, 6 -3H]UTP-labelled RNAs when uridine is converted to [22] . These gel-purified inhibitors were present in 5-fold molar excess over the substrate. The control contains yeast tRNA (0.7 ,ug; -30 pmol), which is used in the gel purification of the Ul, U2 and U5 RNAs, and is therefore present in all of the preparations of inhibitor RNA. The amount of yeast tRNA in the inhibitor RNAs added to the reactions was always less than 30 pmol. The proposed secondary structures for human Ul RNA (a), rat U2 RNA (b) and human U5 RNA (c) [3] are shown, and the locations of T moieties are boxed.
RNAs. After incubation the assembled snRNPs were subjected to centrifugation in glycerol gradients.
[32P]UTP-labelled RNAs from the snRNP peak of each gradient were separated in a 10 % polyacrylamide/8 M urea gel [17, 19, 20] . Bands corresponding to the 32P-labelled Ul, U2 and U5 RNAs were isolated from each reaction, since they migrate at different rates (see Figure 3) , and the RNA was eluted from the gel, digested with nuclease P1 and chromatographed on t.l.c. plates [17, 23] (Figure 4a, lane 4) , but the t.l.c.s for U2 and U5 RNAs do indicate the presence of T (Figures 4b and 4c, lane 4) . Similarly, with U2 RNA, there was [17, 24] . The Ul RNA was digested with nuclease P1 and chromatographed [17, 23] . A portion Ul RNA isolated from Sm monoclonal antibody-reactive U1 snRNP [24] when only a 3-fold molar excess of 3H-labelled 5-FU-containing U] RNA was used as an inhibitor of synthase (80 fmol of substrate and 250 fmol of inhibitor in a100l1l reaction). In addition, Figure 5 shows It is also possible that more than one activity is modifying a single snRNA. A hint that this may be the case comes from the modification of human US RNA in vitro, since only two of the three positions where T has been identified [3] are actually converted to ' [17] . The twoTs (at positions 43 and 46) that are found in the in vitro-assembled US snRNP are located in the terminal loop of the large hairpin loop. The position that is not modified in vitro is located in the stem. Thus the three ' moieties are located in different types of secondary structure, and this may require separate synthase activities with different specificities. In the case of U2 RNA one might speculate that there are even more than two synthase activities because there are 13T residues [3] . Some of these T' residues are in loops, others are in stems, and still others are in single-stranded regions that are not a part of hairpinloops [3] . The experiments presented in this paper do not reveal if more than one activity is modifying a single snRNA, since 5-FU was incorporated throughout the inhibitor RNAs. These types of questions await purification of the enzymes. SeparateT synthases that modify different positions in a single tRNA have been purified from yeast [13, 15] . Three separate activities were found that modified uridine at positions 13, 32 and 55 in the major glycine tRNA of Saccharomyces cerevisiae. In addition, other groups have found evidence that more than one tRNAT synthase activity modifies a single tRNA ( [22] , and references cited therein). Thus there is a strong precedent for multipleT synthases that recognize a single RNA molecule. These tRNA ' synthases are also able to modify more than one type of tRNA [12, 13, 22] , probably due to the structural similarity of most tRNAs.
The function of T in snRNAs is not known, butpseudouridine appears to be necessary for the function of tRNA during 599 translation [6] [7] [8] . Now that it is possible to produce I-deficient snRNPs in vitro, experiments designed to elucidate the function of T in these splicing cofactors will be possible. Understanding the requirement for bound Sm proteins is also a current interest, and the purification of enzymes that form ' in these splicing cofactors is under way. Beyond their bearing on the multiplicity of snRNA ' synthases, the present experiments also reveal that 5-FU-containing snRNAs are highly specific and potent inhibitors of' formation in human cell extracts. Fluoropyrimidines are used in the treatment of certain cancers [29] and their toxicity is assumed to derive from their effect on thymidylate synthase and also their incorporation in cellular RNA [29] . Effects of fluoropyrimidines on the metabolism of snRNAs [30] and on the in vitro splicing of pre-mRNA [31] have been reported. FU incorporation into longlived species such as snRNAs could have profound consequences for the cell by producing inactive snRNPs and thereby inhibiting mRNA splicing. Such a possibility now deserves serious consideration in the clinical use of fluoropyrimidines.
